Since its inception in 2017, the American Oncology Network, LLC (AON) has participated in the Oncology Care Model (OCM), a national innovative payment program of the Center for Medicare & Medicaid Innovation (CMMI).
FORT MYERS, FLA., November 25, 2019 — Since its inception in 2017, the American Oncology Network, LLC (AON) has participated in the Oncology Care Model (OCM), a national innovative payment program of the Center for Medicare & Medicaid Innovation (CMMI). Through its participation in OCM, AON’s affiliated practices are providing high-quality enhanced services to Medicare beneficiaries, such as care coordination, navigation, and national treatment guidelines, while reducing the cost of cancer care through payment arrangements that include financial and performance accountability.
Based on its record of success in community oncology practices across the nation, AON is expanding its participation in the program by choosing to adopt an alternative “2-sided risk” model that would create additional savings for patients and, potentially, for its affiliated practices. In the new 2-sided risk model, providers still share in savings, if spending is below the benchmark, as they do in the previous 1-sided risk model; however, under the 2-sided model, providers also are responsible for some of the loss if spending is above the benchmark.
Brad Prechtl, MBA, CEO of AON, said, “AON’s affiliated practices are community oncology practices that provide extremely high-quality care. Being part of the American Oncology Network allows these practices to provide enhanced services to their patients, such as an in-house specialty pharmacy, world-class pathology lab and national clinical research, as well as the ability to participate in the Oncology Care Model, which, in turn, provides added benefits to patients in their local community.”
For more information, see the full press release here.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
March 28th 2025Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.
Read More